SCHEMBL13699686

SCHEMBL13699686

CC(C)c1ccc2c(N)c(C(N)=O)oc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.50
ALDH1A1 P00352 6/20 0.50
HPGD P15428 4/20 0.50
HSD17B10 Q99714 3/20 0.50
TBK1 Q9UHD2 5/20 0.46
IKBKE Q14164 2/20 0.46
NPC1 O15118 6/20 0.38
RAB9A P51151 5/20 0.38
GAA P10253 2/20 0.38
ABCC4 O15439 1/20 0.38
TTR P02766 1/20 0.38
PKM P14618 1/20 0.38
ADRA1A P35348 1/20 0.38
OPRD1 P41143 1/20 0.38
PDE4D Q08499 1/20 0.38
PDE3A Q14432 1/20 0.38
GPR35 Q9HC97 1/20 0.38
MAPT P10636 5/20 0.38
KMT2A Q03164 3/20 0.38
SMN1; SMN2 Q16637 6/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24845781 0.88 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10TBK1
SCHEMBL13699685 0.80 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10NPC1
SCHEMBL1853021 0.78 KDM4E (0.60) KDM4EALDH1A1HPGDHSD17B10TBK1
SCHEMBL20535434 0.77 KDM4E (0.51) KDM4EALDH1A1HPGDHSD17B10NPC1
SCHEMBL4257410 0.76 KDM4E (0.77) KDM4EALDH1A1HPGDHSD17B10NPC1
SCHEMBL13699669 0.76 KDM4E (0.54) KDM4EALDH1A1HPGDHSD17B10NPC1
SCHEMBL13699674 0.76 KDM4E (0.59) KDM4EALDH1A1HPGDHSD17B10NPC1
SCHEMBL13699688 0.76 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10NPC1
SCHEMBL13699683 0.76 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10NPC1
SCHEMBL20535441 0.73 KDM4E (0.50) KDM4EALDH1A1HPGDHSD17B10NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE KISSEI PHARMACEUTICAL CO., LTD. (JP) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239860-A1 NOVEL BENZOFURAN DERIVATIVE, MEDICINAL COMPOSITION CONTAINING THE SAME, AND USES OF THESE ADORA2A, ADORA2B, HTR1F KDM4E 4227/4885ALDH1A1 559/4885HPGD 3251/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.